Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ELF1 |
| Upstream (Parents) |
|---|
| (<<) HSPH1 → ELF1 |
| (<<) C13orf23 → ELF1 |
| (<<) C13orf34 → ELF1 |
| (<<) NEK3 → ELF1 |
| (<<) SLC25A36 → ELF1 |
| (<<) ANKRD10 → ELF1 |
| Downstream (Children) |
|---|
| ELF1 → IL33 (>>) |
| ELF1 → POU4F1 (>>) |
| ELF1 → DACH1 (>>) |
| ELF1 → DRD2 (>>) |
| ELF1 → MED25 (>>) |
| ELF1 → VAPB (>>) |
| ELF1 → JUN (>>) |
| ELF1 → IRS1 (>>) |
| ELF1 → LRCH1 (>>) |
| ELF1 → SESN1 (>>) |
| ELF1 → STEAP1 (>>) |
| ELF1 → DNAJC15 (>>) |
| ELF1 → RBM5 (>>) |
| ELF1 → STK4 (>>) |
